Health Catalyst Capital Management

Health Catalyst Capital Management is a venture capital firm based in New York, established in 2015. The firm specializes in investing in high-growth healthcare technology companies, focusing on sectors such as healthcare IT, digital health, and healthtech. By targeting businesses with the potential to reach significant enterprise value, Health Catalyst Capital aims to capitalize on new and disrupted markets both in the United States and internationally, including Canada and Europe. As a registered investment adviser, the firm emphasizes growth and expansion opportunities within the healthcare sector, seeking to support innovative companies that can transform the industry.

Joseph Boorady

Senior Operating Partner

Charles Boorady

Founder, Managing Partner and Head of Investment Committee

Peter Costa

Operating Partner

Daniel Ross

Partner and Member of Investment Committee

23 past transactions

Holmusk

Venture Round in 2021
Holmusk Pte. Ltd. is a digital health and data analytics company focused on delivering real-world evidence for mental health and chronic diseases. Founded in 2015 and headquartered in Singapore, with additional offices in New York, Durham, London, and Cyberjaya, Holmusk develops an analytics platform that integrates scientific research, electronic health records, and behavioral health data to provide predictive algorithms and actionable insights for personalized medicine. The company offers solutions such as MindLinc, an electronic health record system that enhances longitudinal data for advanced analytics, and digital therapeutics that monitor and treat patients. Holmusk's platform supports various stakeholders in the healthcare ecosystem, including pharmaceutical companies, healthcare providers, payers, and regulators, facilitating informed care decisions and improving treatment outcomes for individuals managing behavioral health conditions. Through its innovative approach, Holmusk aims to advance data-driven, evidence-based care and aid in the research and development of new therapies.

PierianDx

Venture Round in 2021
PierianDx, Inc. is a technology company that develops a genomic software-as-a-service (SaaS) solution designed to manage, analyze, and interpret complex genomic tests for clinical laboratories in the United States. The company offers the Clinical Genomicist Workstation, a platform that streamlines the workflow for patient cases, handling everything from sequencing and analysis to report generation and integration with electronic health records. PierianDx aims to enhance the adoption of genomic sequencing in healthcare, enabling physicians to diagnose and treat patients with cancer and other complex diseases more effectively. The company also provides consulting and technical services to support its clients, which include health systems, children's hospitals, comprehensive cancer centers, and reference laboratories. Founded in 2014 and headquartered in Saint Louis, Missouri, PierianDx has established itself as a trusted source for advanced genomic reporting and decision support in clinical care.

Click Therapeutics

Series B in 2021
Click Therapeutics, Inc. specializes in the engineering, validation, development, and commercialization of digital therapeutic solutions aimed at addressing unmet medical needs through cognitive and neurobehavioral modification. Founded in 2012 and based in New York, the company offers innovative digital therapeutics for a range of conditions, including smoking cessation, major depressive disorder, schizophrenia, insomnia, and chronic pain. Its Digital Therapeutics™ are designed to function independently or alongside traditional biomedical treatments, utilizing the Clickometrics® adaptive data science platform to personalize user experiences and enhance engagement. Notably, Click's smoking cessation program has gained widespread access through various payers and providers, while its primary prescription program is advancing into a significant phase III clinical trial for major depressive disorder in adults.

Ilumivu

Series A in 2021
Developer of a patient-centered platform designed to capture rich, multimodal behavioral data streams through user engagement. The company's platform provides healthcare decision support applications using the psychology of behavior change, combined with real-time data from smartphones and wearables, enabling patients suffering from diabetes, sleep apnea, and hypertension to effectively measure outcomes and track the process of change.

Pager

Series C in 2021
Pager, Inc. is a digital health technology company that operates an on-demand service platform, connecting patients with healthcare services in various settings, including their homes and workplaces. The company offers a mobile application that addresses urgent care needs, such as infections, allergies, and other health concerns. Pager provides a comprehensive suite of services, including teleconsultations, nurse chat, vaccination, prescription delivery, and aftercare support. Its platform is designed for payers, providers, and employers, facilitating quick and convenient access to care while promoting effective navigation through the healthcare system. Pager's technology enables seamless communication via chat, voice, and video, and integrates artificial intelligence and data tools to enhance collaboration among healthcare teams. Serving approximately 10 million covered lives across the United States and parts of Latin America, Pager aims to deliver a personalized healthcare experience that simplifies patient interactions with care providers. The company was founded in 2013 and is headquartered in New York.

Clearsense

Venture Round in 2021
Clearsense, LLC is a healthcare technology company based in Jacksonville, Florida, established in 2013. It offers a cloud-based data platform designed to provide real-time insights into clinical, operational, and financial metrics for healthcare organizations. The platform integrates various data sources into a single source of truth, which enhances data maturity and optimizes analytics tools. By doing so, Clearsense aims to improve decision-making quality, reduce costs, and increase revenue opportunities while facilitating better healthcare outcomes.

Glooko

Series D in 2021
Glooko is a comprehensive diabetes management platform designed to enhance health outcomes for individuals with diabetes and their healthcare teams. It connects with various diabetes devices and fitness trackers to gather essential data, including glucose levels, food intake, insulin usage, medications, blood pressure, diet, and weight. The platform is utilized in over 7,000 clinical locations and serves more than 1.5 million people with diabetes across 23 countries and in 15 languages. Glooko aims to facilitate remote patient monitoring by providing healthcare providers with valuable insights and analytics, ultimately supporting interventions that improve patient care and promote healthier behaviors.

Insightin Health

Series A in 2021
Insightin Health develops a cloud-based platform that enhances preventative care recommendations for patients within healthcare systems. Founded in 2016 and headquartered in Gaithersburg, Maryland, with an additional office in Pittsburgh, the platform automates campaign management, allowing healthcare organizations to create personalized content and deliver it in real-time. By aggregating data from various sources, the system provides actionable analytics that helps organizations manage member activities effectively. Utilizing artificial intelligence, the platform combines medical, clinical, cognitive, and social determinants of health to suggest tailored next steps for individuals, thereby improving quality measures and member satisfaction while reducing churn. The company's services cater to Medicare/Medicaid, Accountable Care Organizations (ACOs), and other healthcare markets.

Holmusk

Series A in 2020
Holmusk Pte. Ltd. is a digital health and data analytics company focused on delivering real-world evidence for mental health and chronic diseases. Founded in 2015 and headquartered in Singapore, with additional offices in New York, Durham, London, and Cyberjaya, Holmusk develops an analytics platform that integrates scientific research, electronic health records, and behavioral health data to provide predictive algorithms and actionable insights for personalized medicine. The company offers solutions such as MindLinc, an electronic health record system that enhances longitudinal data for advanced analytics, and digital therapeutics that monitor and treat patients. Holmusk's platform supports various stakeholders in the healthcare ecosystem, including pharmaceutical companies, healthcare providers, payers, and regulators, facilitating informed care decisions and improving treatment outcomes for individuals managing behavioral health conditions. Through its innovative approach, Holmusk aims to advance data-driven, evidence-based care and aid in the research and development of new therapies.

ReferWell

Venture Round in 2020
ReferWell connects providers into Virtually Integrated Networks that optimize transitions of care. We help you drive the patient journey through the last mile with complete visibility into all interactions—so providers and payers can close the loop efficiently. With our system, you’ll direct patients toward the highest-quality providers, increase patient compliance, reduce leakage and close more care gaps. Clients raise revenue by increasing keepage, improving STAR ratings and getting more members’ HCC coding updated. Our comprehensive suite of services connects to all your EMRs for streamlined referrals, point-of-care appointment scheduling and care team support, including provider directory management, eConsult and telehealth capabilities.

Pager

Series B in 2020
Pager, Inc. is a digital health technology company that operates an on-demand service platform, connecting patients with healthcare services in various settings, including their homes and workplaces. The company offers a mobile application that addresses urgent care needs, such as infections, allergies, and other health concerns. Pager provides a comprehensive suite of services, including teleconsultations, nurse chat, vaccination, prescription delivery, and aftercare support. Its platform is designed for payers, providers, and employers, facilitating quick and convenient access to care while promoting effective navigation through the healthcare system. Pager's technology enables seamless communication via chat, voice, and video, and integrates artificial intelligence and data tools to enhance collaboration among healthcare teams. Serving approximately 10 million covered lives across the United States and parts of Latin America, Pager aims to deliver a personalized healthcare experience that simplifies patient interactions with care providers. The company was founded in 2013 and is headquartered in New York.

Risalto

Series A in 2019
Risalto Health Inc. is a New York-based company that specializes in developing a platform designed to connect patients, healthcare providers, and concierges through the use of big data. Established in 2016, Risalto Health focuses on addressing inefficiencies in healthcare, particularly in musculoskeletal care. By utilizing data science and an analytics platform, the company assembles a network of healthcare professionals, including doctors, physical therapists, chiropractors, and surgeons, to provide targeted care for conditions such as back, neck, knee, and hip pain. The company's approach emphasizes directing patients to evidence-based treatments, which not only improves health outcomes but also reduces overall care costs.

PierianDx

Series B in 2019
PierianDx, Inc. is a technology company that develops a genomic software-as-a-service (SaaS) solution designed to manage, analyze, and interpret complex genomic tests for clinical laboratories in the United States. The company offers the Clinical Genomicist Workstation, a platform that streamlines the workflow for patient cases, handling everything from sequencing and analysis to report generation and integration with electronic health records. PierianDx aims to enhance the adoption of genomic sequencing in healthcare, enabling physicians to diagnose and treat patients with cancer and other complex diseases more effectively. The company also provides consulting and technical services to support its clients, which include health systems, children's hospitals, comprehensive cancer centers, and reference laboratories. Founded in 2014 and headquartered in Saint Louis, Missouri, PierianDx has established itself as a trusted source for advanced genomic reporting and decision support in clinical care.

Insightin Health

Seed Round in 2019
Insightin Health develops a cloud-based platform that enhances preventative care recommendations for patients within healthcare systems. Founded in 2016 and headquartered in Gaithersburg, Maryland, with an additional office in Pittsburgh, the platform automates campaign management, allowing healthcare organizations to create personalized content and deliver it in real-time. By aggregating data from various sources, the system provides actionable analytics that helps organizations manage member activities effectively. Utilizing artificial intelligence, the platform combines medical, clinical, cognitive, and social determinants of health to suggest tailored next steps for individuals, thereby improving quality measures and member satisfaction while reducing churn. The company's services cater to Medicare/Medicaid, Accountable Care Organizations (ACOs), and other healthcare markets.

Clareto

Series A in 2019
Developer of health information technology designed to bridge the information gap between healthcare and life insurance. The company's technology engages health information exchanges (HIEs), healthcare providers, other data sources and brings the capabilities, expertise, and experience to facilitate the flow of health data, enabling life insurance industries with electronic exchange of health information in support of underwriting, claims, and other business processes.

Medal

Venture Round in 2019
Medal, Inc. is a healthcare company based in San Francisco, California, that specializes in the extraction, transportation, translation, and sharing of medical information. Founded in 2015, the company focuses on facilitating the review, coordination, referral, analysis, billing, and auditing of medical data to enhance efficiency in healthcare administration. As of July 2020, Medal operates as a subsidiary of CIOX Health, further strengthening its capabilities in the healthcare industry.

Simplifeye

Venture Round in 2019
Simplifeye, Inc. develops practice management software solutions tailored for medical professionals, focusing on enhancing patient engagement and communication. The company offers a suite of tools, including Amplify, a live, HIPAA-compliant web chat for patient interaction; Connect, which facilitates telehealth conferencing and allows for the collection of patient consent and insurance information; and a scheduling feature that empowers patients to book appointments directly. Additionally, Simplifeye provides a SaaS platform that integrates wearable technology, such as the Apple Watch, with existing health record systems, allowing providers to monitor patient status and access critical medical information efficiently. Founded in 2014 and based in New York, Simplifeye aims to improve patient management and operational productivity in healthcare settings.

Risalto

Seed Round in 2018
Risalto Health Inc. is a New York-based company that specializes in developing a platform designed to connect patients, healthcare providers, and concierges through the use of big data. Established in 2016, Risalto Health focuses on addressing inefficiencies in healthcare, particularly in musculoskeletal care. By utilizing data science and an analytics platform, the company assembles a network of healthcare professionals, including doctors, physical therapists, chiropractors, and surgeons, to provide targeted care for conditions such as back, neck, knee, and hip pain. The company's approach emphasizes directing patients to evidence-based treatments, which not only improves health outcomes but also reduces overall care costs.

Insightin Health

Seed Round in 2018
Insightin Health develops a cloud-based platform that enhances preventative care recommendations for patients within healthcare systems. Founded in 2016 and headquartered in Gaithersburg, Maryland, with an additional office in Pittsburgh, the platform automates campaign management, allowing healthcare organizations to create personalized content and deliver it in real-time. By aggregating data from various sources, the system provides actionable analytics that helps organizations manage member activities effectively. Utilizing artificial intelligence, the platform combines medical, clinical, cognitive, and social determinants of health to suggest tailored next steps for individuals, thereby improving quality measures and member satisfaction while reducing churn. The company's services cater to Medicare/Medicaid, Accountable Care Organizations (ACOs), and other healthcare markets.

Cardiogram

Venture Round in 2018
Cardiogram lets you analyze and graph heart rate measurements from the Health app (requires a device with a heart rate monitor). With Cardiogram you can see how your heart reacts during an intense workout, track changes to your resting heart rate, track spikes to your heart rate elated to stress, diet or exercise. Users can also share graphs of their heart rate via email, Twitter or Facebook. Cardiogram is used for apple watch and android wear.

BetterDoctor

Series B in 2017
BetterDoctor, Inc. is a company based in San Francisco, California, that specializes in developing web and mobile applications to assist users in finding healthcare providers. Founded in 2011, BetterDoctor allows users to specify the type of doctor they need and select their insurance plan to view a list of verified healthcare professionals. The company's platform provides accurate provider data to health plans, health systems, and various organizations through its API, facilitating the search for doctors and improving healthcare access. BetterDoctor's services have reached millions of users, powering numerous health plans and companies by enhancing the transparency and reliability of doctor data. As of June 2018, BetterDoctor operates as a subsidiary of Quest Analytics, L.L.C.

ReferWell

Private Equity Round in 2016
ReferWell connects providers into Virtually Integrated Networks that optimize transitions of care. We help you drive the patient journey through the last mile with complete visibility into all interactions—so providers and payers can close the loop efficiently. With our system, you’ll direct patients toward the highest-quality providers, increase patient compliance, reduce leakage and close more care gaps. Clients raise revenue by increasing keepage, improving STAR ratings and getting more members’ HCC coding updated. Our comprehensive suite of services connects to all your EMRs for streamlined referrals, point-of-care appointment scheduling and care team support, including provider directory management, eConsult and telehealth capabilities.

PierianDx

Series A in 2016
PierianDx, Inc. is a technology company that develops a genomic software-as-a-service (SaaS) solution designed to manage, analyze, and interpret complex genomic tests for clinical laboratories in the United States. The company offers the Clinical Genomicist Workstation, a platform that streamlines the workflow for patient cases, handling everything from sequencing and analysis to report generation and integration with electronic health records. PierianDx aims to enhance the adoption of genomic sequencing in healthcare, enabling physicians to diagnose and treat patients with cancer and other complex diseases more effectively. The company also provides consulting and technical services to support its clients, which include health systems, children's hospitals, comprehensive cancer centers, and reference laboratories. Founded in 2014 and headquartered in Saint Louis, Missouri, PierianDx has established itself as a trusted source for advanced genomic reporting and decision support in clinical care.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.